DCSIMG

Support grows for moustaches against cancer

editorial image

editorial image

THE MONTH of Movember is here and teams of men in Bridlington have begun their charity challenge to grow their ‘tache and help combat cancer.

For 30 days from Thursday November 1 to Friday November 30, Movember fund-raisers will sport moustaches in a bid to raise money for, and awareness of testicular and prostate cancer.

Staff at Specsavers, Kingsgate, Bridlington, are growing their moustaches as part of a company-wide rally to raise £25,000 for charity.

Marc Kunz, of Bridlington Specsavers, said: “Too many people die of cancer and Movember is the perfect opportunity to remind men to have annual check-ups and to research any history of the disease in their family.

“I hope our customers will back us as we try to raise as much as we can for some important charities. I’m sure that by the end of the month we’ll make for quite an amusing sight together.”

Visit the Specsaver shop to sponsor the team’s Movember efforts.

At the Blue Bell, Burton Agnes, eight staff members have begun their efforts following a clean shave on Thursday November 1.

The team are Michael Hughes, Dom Hebblewhite, Stephen Wardman, Rolson King, Steve Bielby, Joe Edmunson, Dave Johnson and Mick McMahon.

To sponsor the staff at the Blue Bell visit uk.movember.com and search for Blue Bell Mo’s.

Already sporting an impressive moustache for the occasion Mark Grimes, who works in Bridlington, decided to join in after one of his friends was diagnosed with and treated for prostate cancer. He has already raised £130.

He said: “The least that I can do to support him and everyone else out there suffering with similar issues is to wear a silly tash for a month.”

To sponsor Mark visit mobro.co/grimeyreaper.

Following its beginnings in Australia in 2003, Movember has stretched across the globe to raise vital funds and awareness for men’s health, specifically prostate cancer and testicular cancer.

Money raised during Movember is invested in programmes including the Institute of Cancer Reasearch and Prostate Cancer UK.

 

Comments

 
 

Back to the top of the page